For instance, lncRNA MIR22HG is a critical inducer of the Wnt/β-catenin signaling pathway, which provides a potential therapeutic strategy for glioma patients by targeting the lncRNA MIR22HG [6]. This evidence concerns the gene MIR22HG and glioma.